|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4880935A
(en)
|
1986-07-11 |
1989-11-14 |
Icrf (Patents) Limited |
Heterobifunctional linking agents derived from N-succinimido-dithio-alpha methyl-methylene-benzoates
|
|
US4880078A
(en)
|
1987-06-29 |
1989-11-14 |
Honda Giken Kogyo Kabushiki Kaisha |
Exhaust muffler
|
|
IL89220A
(en)
|
1988-02-11 |
1994-02-27 |
Bristol Myers Squibb Co |
Anthracycline immunoconjugates, their production and pharmaceutical compositions containing them
|
|
FI903489A7
(fi)
|
1988-11-11 |
1990-07-10 |
Medical Res Council |
Yhden osan sisältävät ligandit, näitä ligandeja sisältävät reseptorit, menetelmiä niiden valmistamiseksi sekä ligandien ja reseptorien käytt ö
|
|
JPH06507404A
(ja)
|
1991-05-01 |
1994-08-25 |
ヘンリー エム．ジャクソン ファウンデイション フォー ザ アドバンスメント オブ ミリタリー メディスン |
感染性の呼吸性疾患の治療方法
|
|
EP0590058B1
(en)
|
1991-06-14 |
2003-11-26 |
Genentech, Inc. |
HUMANIZED Heregulin ANTIBODy
|
|
US5622929A
(en)
*
|
1992-01-23 |
1997-04-22 |
Bristol-Myers Squibb Company |
Thioether conjugates
|
|
US5934272A
(en)
|
1993-01-29 |
1999-08-10 |
Aradigm Corporation |
Device and method of creating aerosolized mist of respiratory drug
|
|
US6214345B1
(en)
|
1993-05-14 |
2001-04-10 |
Bristol-Myers Squibb Co. |
Lysosomal enzyme-cleavable antitumor drug conjugates
|
|
US6019968A
(en)
|
1995-04-14 |
2000-02-01 |
Inhale Therapeutic Systems, Inc. |
Dispersible antibody compositions and methods for their preparation and use
|
|
EP0871490B1
(en)
|
1995-12-22 |
2003-03-19 |
Bristol-Myers Squibb Company |
Branched hydrazone linkers
|
|
US5985320A
(en)
|
1996-03-04 |
1999-11-16 |
The Penn State Research Foundation |
Materials and methods for enhancing cellular internalization
|
|
US5874064A
(en)
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
|
US5985309A
(en)
|
1996-05-24 |
1999-11-16 |
Massachusetts Institute Of Technology |
Preparation of particles for inhalation
|
|
US5855913A
(en)
|
1997-01-16 |
1999-01-05 |
Massachusetts Instite Of Technology |
Particles incorporating surfactants for pulmonary drug delivery
|
|
DE69732306T2
(de)
|
1997-01-16 |
2006-01-12 |
Massachusetts Institute Of Technology, Cambridge |
Zubereitung von partikelhaltigen arzneimitteln zur inhalation
|
|
ES2198922T3
(es)
|
1998-06-24 |
2004-02-01 |
Advanced Inhalation Research, Inc. |
Particulas porosas grandes emitadas por un inhalador.
|
|
US6019963A
(en)
|
1998-11-20 |
2000-02-01 |
D.S.C. Products, Inc. |
Deodorizing composition containing tea tree and eucalyptus oils
|
|
US7109019B2
(en)
|
1999-01-06 |
2006-09-19 |
The Regents Of The University Of California |
Gene cluster for production of the enediyne antitumor antibiotic C-1027
|
|
IL158532A0
(en)
|
2001-05-02 |
2004-05-12 |
Purdue Research Foundation |
Treatment and diagnosis of macrophage mediated disease
|
|
US7696163B2
(en)
|
2001-10-10 |
2010-04-13 |
Novo Nordisk A/S |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
|
US7265085B2
(en)
|
2001-10-10 |
2007-09-04 |
Neose Technologies, Inc. |
Glycoconjugation methods and proteins/peptides produced by the methods
|
|
US7439043B2
(en)
|
2001-10-10 |
2008-10-21 |
Neose Technologies, Inc. |
Galactosyl nucleotide sugars
|
|
US7297511B2
(en)
|
2001-10-10 |
2007-11-20 |
Neose Technologies, Inc. |
Interferon alpha: remodeling and glycoconjugation of interferon alpha
|
|
US7173003B2
(en)
|
2001-10-10 |
2007-02-06 |
Neose Technologies, Inc. |
Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
|
|
US8008252B2
(en)
|
2001-10-10 |
2011-08-30 |
Novo Nordisk A/S |
Factor VII: remodeling and glycoconjugation of Factor VII
|
|
US7214660B2
(en)
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
|
US7157277B2
(en)
|
2001-11-28 |
2007-01-02 |
Neose Technologies, Inc. |
Factor VIII remodeling and glycoconjugation of Factor VIII
|
|
US7795210B2
(en)
|
2001-10-10 |
2010-09-14 |
Novo Nordisk A/S |
Protein remodeling methods and proteins/peptides produced by the methods
|
|
US7226903B2
(en)
|
2001-10-10 |
2007-06-05 |
Neose Technologies, Inc. |
Interferon beta: remodeling and glycoconjugation of interferon beta
|
|
US7399613B2
(en)
|
2001-10-10 |
2008-07-15 |
Neose Technologies, Inc. |
Sialic acid nucleotide sugars
|
|
US7125843B2
(en)
|
2001-10-19 |
2006-10-24 |
Neose Technologies, Inc. |
Glycoconjugates including more than one peptide
|
|
US7265084B2
(en)
|
2001-10-10 |
2007-09-04 |
Neose Technologies, Inc. |
Glycopegylation methods and proteins/peptides produced by the methods
|
|
US7179617B2
(en)
|
2001-10-10 |
2007-02-20 |
Neose Technologies, Inc. |
Factor IX: remolding and glycoconjugation of Factor IX
|
|
WO2003072754A2
(en)
|
2002-02-27 |
2003-09-04 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Conjugates of ligand, linker and cytotoxic agent and related compositions and methods of use
|
|
ES2369542T3
(es)
*
|
2002-07-31 |
2011-12-01 |
Seattle Genetics, Inc. |
Conjugados de auristatina y su uso para tratar cáncer, una enfermedad autoinmune o una enfermedad infecciosa.
|
|
JP2004119755A
(ja)
|
2002-09-27 |
2004-04-15 |
Alps Electric Co Ltd |
磁気検出素子及びその製造方法
|
|
US20040071540A1
(en)
|
2002-10-15 |
2004-04-15 |
Lucas Philip J. |
Disposable/recyclable pallet system and method
|
|
US20080025989A1
(en)
|
2003-02-20 |
2008-01-31 |
Seattle Genetics, Inc. |
Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
|
|
CA2522345A1
(en)
|
2003-04-09 |
2004-11-18 |
Neose Technologies, Inc. |
Glycopegylation methods and proteins/peptides produced by the methods
|
|
AU2004273910A1
(en)
|
2003-09-18 |
2005-03-31 |
Combinatorx, Incorporated |
Combinations of drugs for the treatment of neoplasms
|
|
US6997024B2
(en)
|
2003-10-01 |
2006-02-14 |
Truth Hardware Corporation |
Pull door lock
|
|
US20050148535A1
(en)
|
2003-10-30 |
2005-07-07 |
Lacasse Eric |
IAP nucleobase oligomers and oligomeric complexes and uses thereof
|
|
US8012944B2
(en)
|
2003-10-30 |
2011-09-06 |
Pharmascience Inc. |
Method for treating cancer using IAP antisense oligomer and chemotherapeutic agent
|
|
CA2556027C
(en)
|
2004-02-12 |
2015-11-24 |
Morphotek, Inc. |
Monoclonal antibodies that specifically block biological activity of a tumor antigen
|
|
US7117807B2
(en)
|
2004-02-17 |
2006-10-10 |
University Of Florida Research Foundation, Inc. |
Dynamically modifiable polymer coatings and devices
|
|
US20080253960A1
(en)
|
2004-04-01 |
2008-10-16 |
The Trustees Of The University Of Pennsylvania Center For Technology Transfer |
Lipoprotein-Based Nanoplatforms
|
|
CA2569003A1
(en)
|
2004-05-07 |
2005-12-08 |
Massachusetts Institute Of Technology |
Methods and compositions for cancer treatment relating to brca1 brct domain recognition of phosphorylated bach1
|
|
KR101434673B1
(ko)
|
2004-06-03 |
2014-08-26 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
할리콘드린 ｂ 유사체의 제조를 위한 중간체
|
|
TR201808537T4
(tr)
|
2004-09-23 |
2018-07-23 |
Genentech Inc |
Sistein değiştirilmiş antikorlar ve konjugatlar.
|
|
JO3000B1
(ar)
*
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
|
JP2008522624A
(ja)
|
2004-12-09 |
2008-07-03 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
ヘミアスタリン（ｈｅｍｉａｓｔｅｒｌｉｎ）アナログを使用する癌治療におけるチューブリンのアイソタイプのスクリーニング
|
|
JP2008522623A
(ja)
|
2004-12-09 |
2008-07-03 |
エーザイ株式会社 |
ハリコンドリンｂアナログを使用した癌治療でのチューブリンアイソタイプのスクリーニング
|
|
WO2007008848A2
(en)
|
2005-07-07 |
2007-01-18 |
Seattle Genetics, Inc. |
Monomethylvaline compounds having phenylalanine carboxy modifications at the c-terminus
|
|
ES2708763T3
(es)
|
2005-07-07 |
2019-04-11 |
Seattle Genetics Inc |
Compuestos de monometilvalina que tienen modificaciones de la cadena lateral de fenilalanina en el extremo C
|
|
GB0515025D0
(en)
|
2005-07-21 |
2005-08-31 |
Novartis Ag |
Organic compounds
|
|
RU2470668C2
(ru)
|
2005-08-19 |
2012-12-27 |
Эндосайт, Инк. |
Конъюгаты лиганда с несколькими лекарственными средствами
|
|
WO2007031734A1
(en)
|
2005-09-14 |
2007-03-22 |
Ucb Pharma S.A. |
Comb polymers
|
|
US8293726B2
(en)
|
2005-12-02 |
2012-10-23 |
Vianova Labs, Inc. |
Treatment of cancer and other diseases
|
|
WO2007128884A1
(en)
|
2006-05-09 |
2007-11-15 |
Oy Jurilab Ltd |
Novel genes and markers in type 2 diabetes and obesity
|
|
US20140037539A1
(en)
|
2012-07-27 |
2014-02-06 |
Rutgers, The State University Of New Jersey |
Antibody cocktails for breast cancer radioimmunotherapy
|
|
US20150030534A1
(en)
|
2013-07-26 |
2015-01-29 |
Rutgers, The State University Of New Jersey |
Antibody cocktails for breast cancer radioimmunotherapy
|
|
US8398956B2
(en)
|
2007-01-11 |
2013-03-19 |
Immunomedics, Inc. |
In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
|
|
US20100104626A1
(en)
|
2007-02-16 |
2010-04-29 |
Endocyte, Inc. |
Methods and compositions for treating and diagnosing kidney disease
|
|
CN104127878A
(zh)
|
2007-03-14 |
2014-11-05 |
恩多塞特公司 |
结合配体连接的微管溶素递药缀合物
|
|
EP1977765A1
(en)
|
2007-04-03 |
2008-10-08 |
Diatos |
Peptide prodrugs
|
|
EP2578576B9
(en)
|
2007-10-03 |
2016-09-14 |
Eisai R&D Management Co., Ltd. |
Intermediates for the synthesis of halichondrin B analogs
|
|
BRPI0818780A2
(pt)
*
|
2007-10-19 |
2015-04-22 |
Genentech Inc |
Anticorpo anti-tenb2 planejados por cisteína e conjugados de medicamento com anticorpos
|
|
WO2009057304A1
(ja)
|
2007-10-30 |
2009-05-07 |
Fujitsu Limited |
携帯端末装置
|
|
WO2009117531A1
(en)
|
2008-03-18 |
2009-09-24 |
Seattle Genetics, Inc. |
Auristatin drug linker conjugates
|
|
EP2279267A4
(en)
|
2008-03-27 |
2012-01-18 |
Vascular Biosciences Inc |
METHOD FOR IDENTIFYING NEW THERAPY CANDIDATES ON GENE EXPRESSION ANALYSIS IN DISEASES RELATED TO VACCINES
|
|
US20100260668A1
(en)
|
2008-04-29 |
2010-10-14 |
Abbott Laboratories |
Dual Variable Domain Immunoglobulins and Uses Thereof
|
|
EP2282769A4
(en)
|
2008-04-29 |
2012-04-25 |
Abbott Lab |
DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND ITS USES
|
|
UA108598C2
(xx)
*
|
2008-04-30 |
2015-05-25 |
|
Високоефективні кон'югати та гідрофільні зшиваючі агенти (лінкери)
|
|
KR20110016959A
(ko)
|
2008-06-03 |
2011-02-18 |
아보트 러보러터리즈 |
이원 가변 도메인 면역글로불린 및 이의 용도
|
|
EP2297209A4
(en)
|
2008-06-03 |
2012-08-01 |
Abbott Lab |
IMMUNOGLOBULINS WITH TWO VARIABLE DOMAINS AND USES THEREOF
|
|
US8822645B2
(en)
|
2008-07-08 |
2014-09-02 |
Abbvie Inc. |
Prostaglandin E2 dual variable domain immunoglobulins and uses thereof
|
|
GEP20135804B
(en)
|
2008-09-12 |
2013-04-10 |
Santen Pharmaceutical Co Ltd |
Glucocorticoid receptor agonist comprising novel 1,2,3,4-tetrahydroquinoxaline derivative containing phenyl group having sulfonic acid ester introduced therein as substituent
|
|
SG171812A1
(en)
|
2008-12-04 |
2011-07-28 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
|
NZ594514A
(en)
|
2009-03-05 |
2013-06-28 |
Abbott Lab |
Interleukin-17 BINDING PROTEINS
|
|
US20140339088A1
(en)
|
2009-03-09 |
2014-11-20 |
Virginia Tech Intellectual Properties, Inc. |
Dielectrophoresis methods for determining a property of a plurality of cancer cells
|
|
WO2010127284A2
(en)
|
2009-05-01 |
2010-11-04 |
Abbott Laboratories |
Dual variable domain immunoglobulins and uses thereof
|
|
US8686520B2
(en)
*
|
2009-05-29 |
2014-04-01 |
International Business Machines Corporation |
Spin-torque magnetoresistive structures
|
|
TW201109438A
(en)
|
2009-07-29 |
2011-03-16 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
|
KR20120107069A
(ko)
*
|
2009-08-15 |
2012-09-28 |
제넨테크, 인크. |
이전에 치료된 유방암의 치료를 위한 항혈관신생 요법
|
|
MX2012002651A
(es)
|
2009-09-01 |
2012-05-22 |
Abbott Lab |
Inmunoglobulinas de dominio variable doble y usos de las mismas.
|
|
GB0917044D0
(en)
|
2009-09-29 |
2009-11-18 |
Cytoguide As |
Agents, uses and methods
|
|
AR078651A1
(es)
|
2009-10-15 |
2011-11-23 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
UY32979A
(es)
|
2009-10-28 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
JP2013510166A
(ja)
|
2009-11-06 |
2013-03-21 |
プレキシコン インコーポレーテッド |
キナーゼ調節のための化合物、方法およびその適用
|
|
US8203010B2
(en)
|
2010-01-26 |
2012-06-19 |
Eisai R&D Management Co., Ltd. |
Compounds useful in the synthesis of halichondrin B analogs
|
|
US8710035B2
(en)
|
2010-03-24 |
2014-04-29 |
The University Of Chicago |
Methods and compositions related to glucocorticoid receptor antagonists and breast cancer
|
|
EP2549863A4
(en)
|
2010-03-24 |
2014-01-01 |
Univ Ohio |
COMPOSITIONS AND METHODS FOR GLUCOSE TRANSPORTATION
|
|
TWI500427B
(zh)
|
2010-05-14 |
2015-09-21 |
Abbvie Inc |
Ｉｌ－１結合蛋白
|
|
JP6055404B2
(ja)
|
2010-06-15 |
2016-12-27 |
ゲンマブ エー／エス |
組織因子に対するヒト抗体薬物結合体
|
|
UY33492A
(es)
|
2010-07-09 |
2012-01-31 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
KR20130100118A
(ko)
|
2010-08-03 |
2013-09-09 |
아비에 인코포레이티드 |
이원 가변 도메인 면역글로불린 및 이의 용도
|
|
US9046513B2
(en)
|
2010-08-26 |
2015-06-02 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
|
US9089570B2
(en)
|
2010-09-03 |
2015-07-28 |
Tactical Therapeutics Inc |
Compositions for treating cancers having acquired resitance to prior chemotherapeutic and targeted drugs using carboxyamidotriazole orotate
|
|
EP2613810B9
(en)
|
2010-09-07 |
2016-02-17 |
Johannes Kepler Universität Linz |
Biodegradable, water soluble and ph responsive poly(organo)phosphazenes
|
|
WO2012065057A2
(en)
|
2010-11-12 |
2012-05-18 |
Exelixis, Inc. |
Phosphatidylinositol 3-kinase inhibitors and methods of their use
|
|
WO2012065019A2
(en)
|
2010-11-12 |
2012-05-18 |
Exelixis, Inc. |
Pyridopyrimidinone inhibitors of p13k alpha
|
|
CA2814962A1
(en)
|
2010-12-02 |
2012-06-07 |
Immunomedics, Inc. |
In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
|
|
MX2013007332A
(es)
|
2010-12-21 |
2014-01-23 |
Abbvie Inc |
Inmunoglobulinas de dominio variable doble biespecificas de il-1 alfa y beta y su uso.
|
|
US20120195900A1
(en)
|
2010-12-22 |
2012-08-02 |
Abbott Laboratories |
Tri-variable domain binding proteins and uses thereof
|
|
US20120201746A1
(en)
|
2010-12-22 |
2012-08-09 |
Abbott Laboratories |
Half immunoglobulin binding proteins and uses thereof
|
|
DK2675474T3
(en)
|
2011-02-15 |
2019-04-23 |
Vaxiion Therapeutics Llc |
THERAPEUTIC COMPOSITIONS AND PROCEDURES FOR TARGETED ADMINISTRATION OF BIOACTIVE MOLECULES BY BACK-TERIAL MINICLES BASED ON ANTIBODY AND FC-CONTAINING TAR-GETING MOLECULES
|
|
US9597340B2
(en)
|
2011-02-25 |
2017-03-21 |
Arena Pharmaceuticals, Inc. |
Cannabinoid receptor modulators
|
|
WO2012119077A1
(en)
|
2011-03-02 |
2012-09-07 |
Morphotek Inc. |
Co -administration of eribulin and farletuzumab for the treatment of breast cancer
|
|
WO2012118978A1
(en)
|
2011-03-03 |
2012-09-07 |
The Regents Of The University Of Colorado, A Body Corporate |
Methods for treating oncovirus positive cancers
|
|
CN103502218B
(zh)
|
2011-03-04 |
2016-08-17 |
生命科技公司 |
用于缀合生物分子的化合物和方法
|
|
JP5971769B2
(ja)
|
2011-03-15 |
2016-08-17 |
ザ ユニバーシティー オブ ノースカロライナ アット チャペル ヒル |
アントラサイクリン療法を用いて乳癌を処置する方法
|
|
EP2686441B1
(en)
|
2011-03-18 |
2019-05-08 |
Eisai R&D Management Co., Ltd. |
Methods and uses for predicting response to eribulin
|
|
EP2508525A1
(en)
|
2011-04-05 |
2012-10-10 |
Bayer Pharma Aktiengesellschaft |
Substituted 2,3-dihydroimidazo[1,2-c]quinazoline salts
|
|
EP2670866A4
(en)
|
2011-04-05 |
2015-09-02 |
Translational Genomics Res Inst |
BIOMARKERS AND METHOD OF APPLICATION THEREFOR
|
|
WO2012145098A1
(en)
|
2011-04-21 |
2012-10-26 |
Saint Louis University |
Use of adenosine a3 receptor agonists for treatment of neuropathic pain
|
|
DK2714685T3
(en)
|
2011-05-27 |
2017-01-09 |
Ambrx Inc |
FORMATIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACID BOUND dolastatin
|
|
KR20200128601A
(ko)
|
2011-05-27 |
2020-11-13 |
암브룩스, 인코포레이티드 |
비-천연 아미노산 연결된 돌라스타틴 유도체를 함유하는 조성물, 이를 수반하는 방법, 및 용도
|
|
WO2012170640A1
(en)
|
2011-06-07 |
2012-12-13 |
The Trustees Of Columbia University In The City Of New York |
Methods and compositions for trail-drug combination therapy
|
|
US8815226B2
(en)
|
2011-06-10 |
2014-08-26 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
|
EP2717916B1
(en)
|
2011-06-10 |
2017-03-08 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
|
CA2842492A1
(en)
|
2011-08-05 |
2013-02-14 |
Bioasis Technologies, Inc. |
P97 fragments with transfer activity
|
|
CA2857385A1
(en)
|
2011-11-30 |
2013-06-06 |
Alphora Research Inc. |
Process for preparation of (3r)-2,4-di-leaving group-3-methylbut-1-ene
|
|
JP2015501818A
(ja)
|
2011-12-16 |
2015-01-19 |
アルフォラ リサーチ インコーポレイテッドＡｌｐｈｏｒａ Ｒｅｓｅａｒｃｈ Ｉｎｃ． |
３−（（２ｓ，５ｓ）−４−メチレン−５−（３−オキソプロピル）テトラヒドロフラン−２−イル）プロパノール誘導体およびそれらの有用な中間体を調製する方法
|
|
EP3539982B1
(en)
|
2011-12-23 |
2025-02-19 |
Pfizer Inc. |
Engineered antibody constant regions for site-specific conjugation and methods and uses therefor
|
|
CA2858806A1
(en)
|
2011-12-23 |
2013-06-27 |
Innate Pharma |
Enzymatic conjugation of polypeptides
|
|
IN2014MN01521A
(enExample)
|
2011-12-29 |
2015-05-01 |
Alphora Res Inc |
|
|
TWI573792B
(zh)
|
2012-02-01 |
2017-03-11 |
歐陸斯迪公司 |
新穎治療劑
|
|
WO2013130093A1
(en)
*
|
2012-03-02 |
2013-09-06 |
Genentech, Inc. |
Biomarkers for treatment with anti-tubulin chemotherapeutic compounds
|
|
WO2013138371A1
(en)
|
2012-03-12 |
2013-09-19 |
Merrimack Pharmaceuticals, Inc. |
Methods for treating pancreatic cancer using combination therapies comprising an anti-erbb3 antibody
|
|
US9358235B2
(en)
*
|
2012-03-19 |
2016-06-07 |
Plexxikon Inc. |
Kinase modulation, and indications therefor
|
|
AU2013240191B2
(en)
|
2012-03-29 |
2018-02-22 |
Altor Bioscience Corporation |
Methods for treating neoplasia
|
|
CN104334562A
(zh)
|
2012-03-30 |
2015-02-04 |
阿方拉研究股份有限公司 |
用于制备软海绵素b的大环c1-酮类似物的合成方法及其中有用的中间体
|
|
CN104684579A
(zh)
|
2012-04-02 |
2015-06-03 |
梅里麦克制药股份有限公司 |
单特异性的和双特异性的抗-IGF-1R 和抗-ErbB3 抗体的剂量和施用
|
|
CN104640572B
(zh)
|
2012-05-15 |
2018-04-27 |
索伦托医疗有限公司 |
药物偶联物，偶联方法，及其用途
|
|
WO2013172955A1
(en)
|
2012-05-15 |
2013-11-21 |
Diatech Oncology |
Tumor cell isolation/purification process and methods for use thereof
|
|
EP3536700A1
(en)
|
2012-06-07 |
2019-09-11 |
Ambrx, Inc. |
Prostate-specific membrane antigen antibody drug conjugates
|
|
CN104379163A
(zh)
|
2012-06-08 |
2015-02-25 |
霍夫曼-拉罗奇有限公司 |
用于治疗癌症的磷酸肌醇3激酶抑制剂化合物和化疗剂的突变选择性及组合
|
|
CN111499684B
(zh)
|
2012-06-19 |
2024-10-22 |
Ambrx公司 |
抗cd70抗体药物结合物
|
|
JP2015530072A
(ja)
|
2012-06-29 |
2015-10-15 |
ナノストリング テクノロジーズ，インコーポレイティド |
ゲムシタビン療法による乳癌の治療方法
|
|
US9220695B2
(en)
|
2012-06-29 |
2015-12-29 |
The Research Foundation For The State University Of New York |
Polyenolic zinc-binding agents (pezbins) actively promote inactivation of cancer stem cells and potentiate cytotoxic anti-tumor drug substances
|
|
PL2872157T3
(pl)
|
2012-07-12 |
2020-07-13 |
Hangzhou Dac Biotech Co., Ltd |
Koniugaty wiążących komórkę cząsteczek ze środkami cytotoksycznymi
|
|
US20140069822A1
(en)
|
2012-09-10 |
2014-03-13 |
Antec Leyden B.V. |
Electrochemical reduction of disulfide bonds in proteinaceous substances and electrochemical cell for carrying out such reduction
|
|
US9872919B2
(en)
|
2012-09-19 |
2018-01-23 |
The Research Foundation For The State University Of New York |
Prodrugs for selective anticancer therapy
|
|
AU2013326463B2
(en)
|
2012-10-04 |
2018-01-18 |
Ab Science |
Use of masitinib for treatment of cancer in patient subpopulations identified using predictor factors
|
|
WO2014058317A1
(en)
|
2012-10-10 |
2014-04-17 |
Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis |
Methods and means for predicting resistance to anti-cancer treatment
|
|
CN103775148A
(zh)
|
2012-10-22 |
2014-05-07 |
张玉良 |
自冷式热力做功方法
|
|
HRP20180268T4
(hr)
|
2012-10-23 |
2026-03-27 |
Synaffix B.V. |
Modificirano antitijelo, konjugat antitijela i postupak za njihovu pripremu
|
|
MX340090B
(es)
|
2012-11-05 |
2016-06-23 |
Pfizer |
Analogos de spliceostatina.
|
|
US10131682B2
(en)
|
2012-11-24 |
2018-11-20 |
Hangzhou Dac Biotech Co., Ltd. |
Hydrophilic linkers and their uses for conjugation of drugs to a cell binding molecules
|
|
HK1220640A1
(zh)
|
2012-12-03 |
2017-05-12 |
Calithera Biosciences, Inc. |
用谷氨醯胺酶的杂环抑制剂治疗癌症
|
|
TW201425336A
(zh)
*
|
2012-12-07 |
2014-07-01 |
Amgen Inc |
Ｂｃｍａ抗原結合蛋白質
|
|
US9243058B2
(en)
|
2012-12-07 |
2016-01-26 |
Amgen, Inc. |
BCMA antigen binding proteins
|
|
WO2014093394A1
(en)
|
2012-12-10 |
2014-06-19 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
|
US10226535B2
(en)
|
2012-12-10 |
2019-03-12 |
Mersana Therapeutics, Inc. |
Auristatin compounds and conjugates thereof
|
|
US9872918B2
(en)
|
2012-12-12 |
2018-01-23 |
Mersana Therapeutics, Inc. |
Hydroxyl-polymer-drug-protein conjugates
|
|
US20150314007A1
(en)
|
2012-12-21 |
2015-11-05 |
Glykos Finland Oy |
Linker-payload molecule conjugates
|
|
US20150182634A1
(en)
|
2012-12-28 |
2015-07-02 |
Cody P. Coyne |
Molecular Design and Chemical Synthesis of Pharmaceutical-Ligands and Pharmaceutical-Pharmaceutical Analogs with Multiple Mechanisms of Action
|
|
US9695153B2
(en)
|
2013-01-19 |
2017-07-04 |
New York University |
Oligooxopiperazines for p53 reactivation
|
|
WO2014113792A1
(en)
|
2013-01-19 |
2014-07-24 |
New York University |
Hydrogen-bond surrogate peptides and peptidomimetics for p53 reactivation
|
|
WO2014121235A2
(en)
|
2013-02-01 |
2014-08-07 |
Zoneone Pharma, Inc. |
Transformation of drug cyclodextrin complex compositions into compositions of mixtures of lipid vesicle encapsulated drug and cyclodextrin drug complexes
|
|
KR102310786B1
(ko)
|
2013-02-01 |
2021-10-12 |
존원 파마, 인코포레이티드 |
리포좀 내로 난수용성 약물의 원격 부하
|
|
WO2014124322A1
(en)
|
2013-02-08 |
2014-08-14 |
University Of Louisville Research Foundation, Inc. |
Nanoparticles for drug delivery
|
|
US9333211B2
(en)
|
2013-02-22 |
2016-05-10 |
University Of Houston System |
Phosphaplatin mediated modulation of pigment epithelial derived factor and uses thereof
|
|
US9376437B2
(en)
|
2013-03-13 |
2016-06-28 |
Oncoceutics, Inc |
7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, salts thereof and methods of using the same in combination therapy
|
|
ES2687439T3
(es)
*
|
2013-03-13 |
2018-10-25 |
Medimmune Limited |
Pirrolobenzodiazepinas y conjugados de las mismas
|
|
WO2015073072A1
(en)
|
2013-11-15 |
2015-05-21 |
Oncoceutics, Inc. |
7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1h)-one
|
|
PL2968294T3
(pl)
|
2013-03-13 |
2019-10-31 |
Oncoceutics Inc |
7-Benzylo-10-(2-metylobenzylo)-2,6,7,8,9,10-heksahydroimidazo[1,2-a]pirydo[4,3-d]pirymidyn-5(3H)-on do zastosowania w leczeniu nowotworu
|
|
WO2014160360A1
(en)
|
2013-03-14 |
2014-10-02 |
Mersana Therapeutics Inc. |
Tubulysin compounds and conjugates thereof
|
|
US20160038456A1
(en)
|
2013-03-14 |
2016-02-11 |
University Of Florida Research Foundation, Incorporated |
Regulation of cancer using natural compounds and/or diet
|
|
US20140271923A1
(en)
|
2013-03-14 |
2014-09-18 |
Christopher Brian Reid |
Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions
|
|
HK1220626A1
(zh)
|
2013-03-15 |
2017-05-12 |
The Centre For Drug Research And Development |
具细胞毒性和抗有丝分裂的化合物以及其使用方法
|
|
US9295731B2
(en)
|
2013-04-01 |
2016-03-29 |
Mark Quang Nguyen |
Cleavable drug conjugates, compositions thereof and methods of use
|
|
WO2014168721A2
(en)
|
2013-04-12 |
2014-10-16 |
Tufts Medical Center |
Methods and systems for designing and/or characterizing soluble lipidated ligand agents
|
|
EP2988786A4
(en)
|
2013-04-22 |
2016-12-21 |
Avelas Biosciences Inc |
COMPOSITIONS FOR SELECTIVE DRUG ADMINISTRATION AND METHOD OF USE
|
|
GB2513405A
(en)
|
2013-04-26 |
2014-10-29 |
Adc Biotechnology Ltd |
Method of synthesising ADCs using affinity resins
|
|
DK2991683T3
(da)
|
2013-05-02 |
2019-11-04 |
Glykos Finland Oy |
Konjugater af et glykoprotein eller en glykan med en toksisk ladning
|
|
US9650397B2
(en)
|
2013-05-15 |
2017-05-16 |
Alphora Research Inc. |
3-((2S,5S)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives, their preparation and intermediates useful thereof
|
|
GB201309807D0
(en)
|
2013-05-31 |
2013-07-17 |
Pharma Mar Sau |
Antibody drug conjugates
|
|
US20140363454A1
(en)
|
2013-06-06 |
2014-12-11 |
Igenica Biotherapeutics, Inc. |
Antibody-Drug Conjugates, Compositions and Methods of Use
|
|
US11229711B2
(en)
|
2013-06-06 |
2022-01-25 |
Magenta Therapeutics, Inc. |
Linkers for antibody-drug conjugates and related compounds, compositions, and methods of use
|
|
WO2014202773A1
(en)
|
2013-06-20 |
2014-12-24 |
Innate Pharma |
Enzymatic conjugation of polypeptides
|
|
KR20160042871A
(ko)
|
2013-06-21 |
2016-04-20 |
이나뜨 파르마, 에스.아. |
폴리펩티드의 효소적 콘쥬게이션
|
|
US20160299147A1
(en)
|
2013-06-26 |
2016-10-13 |
Afg Technologies S.À.R.L. |
Screening, diagnosis, prognostication and treatment of ovarian cancer
|
|
WO2015000070A1
(en)
|
2013-07-03 |
2015-01-08 |
Alphora Research Inc. |
Synthetic process for preparation of macrocyclic c1-keto analogs of halichondrin b and intermediates useful therein including intermediates containing -so2-(p-tolyl) groups
|
|
WO2015017729A1
(en)
|
2013-07-31 |
2015-02-05 |
Virginia Tech Intellectual Properties, Inc. |
Dielectrophoresis methods for determining a property of a plurality of cancer cells
|
|
WO2015017034A1
(en)
|
2013-08-02 |
2015-02-05 |
Gourdie Robert G |
Methods of treating a cancer through targeted disruption of alpha connexin 43-zonula occludens-1 (zo-1) interaction
|
|
CA2922529A1
(en)
|
2013-08-28 |
2015-03-05 |
Stemcentrx, Inc. |
Novel sez6 modulators and methods of use
|
|
US20150093399A1
(en)
|
2013-08-28 |
2015-04-02 |
Bioasis Technologies, Inc. |
Cns-targeted conjugates having modified fc regions and methods of use thereof
|
|
JP2016531915A
(ja)
|
2013-08-28 |
2016-10-13 |
ステムセントリックス， インコーポレイテッド |
部位特異的抗体コンジュゲーション方法および組成物
|
|
AU2014317843A1
(en)
|
2013-09-09 |
2016-03-24 |
British Columbia Cancer Agency Branch |
Methods and kits for predicting outcome and methods and kits for treating breast cancer with radiation therapy
|
|
WO2015038426A1
(en)
|
2013-09-13 |
2015-03-19 |
Asana Biosciences, Llc |
Self-immolative linkers containing mandelic acid derivatives, drug-ligand conjugates for targeted therapies and uses thereof
|
|
US20150093331A1
(en)
|
2013-10-01 |
2015-04-02 |
OncoLock Co., Ltd. |
Biomarkers for breast cancer
|
|
US9878049B2
(en)
|
2013-10-09 |
2018-01-30 |
The University Of Akron |
High drug loading system to co-deliver anticancer drugs and nucleic acids for cancer therapy
|
|
EP3054987B1
(en)
|
2013-10-11 |
2019-10-09 |
The United States of America, represented by the Secretary, Department of Health and Human Services |
Tem8 antibodies and their use
|
|
WO2015054659A1
(en)
|
2013-10-11 |
2015-04-16 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
|
CA2927022C
(en)
|
2013-10-11 |
2018-08-21 |
Asana Biosciences, Llc |
Protein-polymer-drug conjugates
|
|
US9617521B2
(en)
|
2013-10-21 |
2017-04-11 |
Hemoshear, Llc |
In vitro model for a tumor microenvironment
|
|
CA2929084C
(en)
|
2013-11-04 |
2022-01-11 |
Eisai R&D Management Co., Ltd. |
Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin b
|
|
US9457019B2
(en)
|
2013-11-07 |
2016-10-04 |
Deciphera Pharmaceuticals, Llc |
Methods for inhibiting tie-2 kinase useful in the treatment of cancer
|
|
AU2013404949B2
(en)
|
2013-11-07 |
2018-10-18 |
Deciphera Pharmaceuticals, Llc |
Methods for inhibiting TIE2 kinase useful in the treatment of cancer
|
|
SMT201900291T1
(it)
|
2013-11-15 |
2019-07-11 |
Oncoceutics Inc |
7-benzil-4-(2-metilbenzil)-2,4,6,7,8,9-esaidriomidazo[1,2-a]pirido[3,4-e]pirimidin-5(1h)-one, suoi sali e metodi d'uso
|
|
CN115504924A
(zh)
|
2013-11-27 |
2022-12-23 |
雷德伍德生物科技股份有限公司 |
肼基-吡咯并化合物及用于生成缀合物的方法
|
|
BR112016012237B1
(pt)
|
2013-12-06 |
2023-02-07 |
Eisai R&D Management Co., Ltd |
Métodos úteis na síntese de análogos de halicondrina b
|
|
WO2015095784A1
(en)
|
2013-12-19 |
2015-06-25 |
Luminus Biosciences, Inc. |
Solid nanoparticle formulation of microtubule inhibitors with reduced ostwald ripening for oral administration
|
|
EP3092027A4
(en)
|
2014-01-10 |
2017-09-06 |
Atossa Genetics Inc. |
Transpapillary methods and compositions for diagnosing and treating breast conditions
|
|
AU2015204572B2
(en)
|
2014-01-10 |
2020-07-30 |
Inspirna, Inc. |
LXR agonists and uses thereof
|
|
EP3092256B1
(en)
|
2014-01-10 |
2022-05-18 |
Birdie Biopharmaceuticals Inc. |
Compounds and compositions for immunotherapy
|
|
CN104784699B
(zh)
|
2014-01-20 |
2019-05-03 |
博瑞生物医药（苏州）股份有限公司 |
叶酸受体结合配体-药物偶联物
|
|
AU2015211674A1
(en)
*
|
2014-02-03 |
2016-08-04 |
Nanocarrier Co., Ltd. |
Anti-tissue factor monoclonal antibody
|
|
EP3730154B1
(en)
|
2014-02-03 |
2021-06-30 |
Eidgenössiche Technische Hochschule Zürich |
Small molecule drug conjugates
|
|
EP2913064A1
(en)
|
2014-02-26 |
2015-09-02 |
celares GmbH |
Branched drug-linker conjugates for the coupling to biological targeting molecules
|
|
TW201617326A
(zh)
|
2014-03-06 |
2016-05-16 |
Ａｌｐｈｏｒａ研發股份有限公司 |
（ｓ）－１－（（２ｒ，３ｒ，４ｓ，５ｓ）－５－烯丙－３－甲氧－４－（對甲苯磺醯甲基）四氫呋喃－２－基）－３－氨基丙－２－醇之結晶衍生物
|
|
MA39740A
(fr)
|
2014-03-13 |
2017-01-18 |
Hoffmann La Roche |
Méthodes et compositions pour moduler des mutants du récepteur des oestrogènes
|
|
US9260478B2
(en)
*
|
2014-04-04 |
2016-02-16 |
Shanghui Hu |
Potent and efficient cytotoxic peptides and antibody-drug conjugates thereof and their synthesis
|
|
JP2017515800A
(ja)
|
2014-04-08 |
2017-06-15 |
ザ・メソジスト・ホスピタル |
ｉＮＯＳ阻害組成物および乳がん治療薬としてのその使用
|
|
US20170035894A1
(en)
|
2014-04-14 |
2017-02-09 |
Endocyte, Inc. |
Drug delivery conjugates for treating resistant cancer and for use in combination therapy
|
|
WO2015161247A1
(en)
*
|
2014-04-17 |
2015-10-22 |
Igenica Biotherapeutics, Inc. |
Humanized anti-c16orf54 antibodies and methods of use thereof
|
|
MX378281B
(es)
*
|
2014-04-25 |
2025-03-10 |
Pf Medicament |
Conjugado farmaco-anticuerpo y su uso para el tratamiento contra el cancer.
|
|
KR101628872B1
(ko)
*
|
2014-05-28 |
2016-06-09 |
주식회사 레고켐 바이오사이언스 |
자가-희생 기를 포함하는 화합물
|
|
US9808528B2
(en)
*
|
2014-06-18 |
2017-11-07 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates and methods of using same
|
|
TWI695011B
(zh)
*
|
2014-06-18 |
2020-06-01 |
美商梅爾莎納醫療公司 |
抗ｈｅｒ２表位之單株抗體及其使用之方法
|
|
WO2016008112A1
(en)
*
|
2014-07-16 |
2016-01-21 |
Medshine Discovery Inc. |
Linkers and application towards adc thereof
|
|
EP3069734A1
(en)
*
|
2015-03-17 |
2016-09-21 |
Exiris S.r.l. |
Cryptophycin-based antibody-drug conjugates with novel self-immolative linkers
|
|
US10975112B2
(en)
*
|
2015-06-16 |
2021-04-13 |
Hangzhou Dac Biotech Co., Ltd. |
Linkers for conjugation of cell-binding molecules
|
|
CN116726190A
(zh)
|
2015-06-20 |
2023-09-12 |
杭州多禧生物科技有限公司 |
澳瑞他汀类似物及其与细胞结合分子的共轭偶联物
|
|
MY199595A
(en)
*
|
2016-03-02 |
2023-11-08 |
Eisai R&D Man Co Ltd |
Eribulin-based antibody-drug conjugates and methods of use
|